What is the Nuclear Medicine Equipment Market Size in 2026?

The global nuclear medicine equipment market was valued at USD 7.34 billion in 2025 and is projected to grow from USD 7.57 billion in 2026 to approximately USD 10.00 billion by 2035, expanding at a CAGR of 3.14% from 2026 to 2035. The market is experiencing steady growth due to the rising prevalence of cancer and cardiovascular diseases, along with the increasing demand for advanced diagnostic imaging technologies. Expanding healthcare infrastructure in emerging economies and the growing preference for minimally invasive diagnostic procedures are also contributing to market expansion.

Read Also: Anti-Snoring Devices Market

Market Overview

The nuclear medicine equipment market refers to the global industry focused on diagnostic imaging technologies that use radioactive tracers to visualize physiological processes inside the human body. These systems play a crucial role in detecting diseases, monitoring treatment responses, and supporting precision medicine.

Major technologies used in nuclear medicine include:

• SPECT (Single Photon Emission Computed Tomography)

• PET (Positron Emission Tomography)

• Hybrid imaging systems such as PET/CT and SPECT/CT

• Planar scintigraphy systems

These technologies are widely used across several clinical applications, including oncology, cardiology, neurology, and metabolic disorder diagnostics.

The increasing prevalence of cancer, cardiovascular diseases, and neurological disorders is significantly boosting the demand for advanced imaging systems. Nuclear medicine technologies allow early disease detection, improved treatment planning, and precise monitoring of therapy outcomes, which enhances overall patient care.

Nuclear Medicine Equipment Market Key Takeaways

• North America dominated the market with a 43% share in 2025.

• Asia Pacific is expected to grow at the fastest CAGR of 5.0% between 2026 and 2035.

• By product, the SPECT systems segment held the largest market share of 58% in 2025.

• The hybrid PET/SPECT/CT segment is expected to grow at a CAGR of 3.9% during the forecast period.

• By application, the oncology segment accounted for 50% market share in 2025.

• The neurology segment is projected to grow at a CAGR of 4.0% between 2026 and 2035.

• By end user, hospitals held the largest share of 60% in 2025.

• Imaging centers are expected to grow at the fastest CAGR of 4.1% during the forecast period.

• By detector technology, the NaI segment accounted for 70% market share in 2025.

• The solid-state/CZT detector segment is expected to expand at a CAGR of 4.3%.

Key Trends in the Nuclear Medicine Equipment Market

Adoption of Hybrid Imaging Systems

Hybrid imaging systems such as PET/CT and SPECT/CT are gaining widespread adoption because they combine functional imaging with anatomical imaging in a single scan. This integration provides more comprehensive and accurate diagnostic insights.

Rising Focus on Early Disease Diagnosis

The growing emphasis on early detection of cancer and cardiovascular diseases is driving strong demand for advanced nuclear medicine imaging systems in hospitals and diagnostic centers.

Continuous Technological Advancements

Advances in imaging technology are improving image resolution, scanning speed, and software capabilities, enabling better disease detection and clinical outcomes.

Integration of Artificial Intelligence

AI integration in nuclear medicine systems helps automate imaging workflows, enhance image analysis, and improve the efficiency of diagnostic processes.

Growth in Personalized Medicine

Nuclear imaging plays an important role in personalized medicine, helping clinicians develop targeted treatment plans based on individual patient conditions.

Expansion of Radiopharmaceutical Applications

The development of new radiotracers and radiopharmaceuticals is expanding the clinical applications of nuclear medicine across oncology, cardiology, and neurology.

Rising Healthcare Investments

Increasing investments in healthcare infrastructure and diagnostic technologies are encouraging the adoption of modern nuclear medicine equipment worldwide.

Growing Demand in Emerging Economies

Rapid healthcare development in emerging markets is creating significant opportunities for nuclear medicine equipment manufacturers.

Future Market Outlook

Increasing Oncology Applications

The rising global burden of cancer is expected to drive strong demand for nuclear imaging systems that enable accurate tumor detection, staging, and treatment monitoring.

Innovation in Radiotracers

Continuous advancements in radiopharmaceutical research are expected to open new diagnostic and therapeutic possibilities in nuclear medicine.

Expanding Opportunities in Emerging Markets

Developing economies with improving healthcare infrastructure present strong opportunities for nuclear medicine equipment manufacturers.

Replacement of Conventional Systems

Many healthcare facilities are replacing standalone imaging systems with hybrid imaging technologies, which will drive equipment upgrades and market growth.

Nuclear Medicine Equipment Market Supply Chain Analysis

Research & Development

Companies are investing heavily in hybrid imaging technologies, AI-driven diagnostics, and advanced detector systems to improve imaging performance and reduce radiation exposure.

Raw Material Sourcing

Essential components such as detectors, collimators, electronics, and radiopharmaceuticals are sourced from specialized suppliers.

Manufacturing & Assembly

Manufacturers assemble systems such as PET scanners, SPECT systems, and gamma cameras, integrating hardware, software, and safety systems.

Distribution

Equipment is distributed primarily to hospitals and diagnostic centers, often through direct sales networks and partnerships with radiopharmacies.

Patient Support Services

Companies provide training, remote monitoring, service contracts, and workflow optimization tools to ensure efficient system operation.

Key Companies in the Nuclear Medicine Equipment Market

• GE HealthCare

• Siemens Healthineers

• Philips Healthcare

• Canon Medical Systems

• Spectrum Dynamics Medical

• Bruker Corporation

• MR Solutions Ltd.

• CUBRESA Inc.

• Digirad Corporation

• DDD-Diagnostics A/S

• Neusoft Medical Systems

• Mediso Ltd.

• Shenzhen Anke High-tech Co., Ltd.

• United Imaging Healthcare

• Positron Corporation

Get Sample: https://www.precedenceresearch.com/checkout/7996